Rosacea: all 231 studies
Page 3 of 3. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.
- An Evaluation of PDI-320 in Comparison to Its Monads in Adults With RosaceaStatus unknownNCT01828177Phase 2
- A Twelve Week Safety and Efficacy Study in RosaceaCompletedNCT01784133Phase 2
- Feasibility Study: Ulthera System for the Treatment of RosaceaCompletedNCT01756027Not applicable
- A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in RosaceaCompletedNCT01740934Not applicable
- Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)CompletedNCT01666509Not applicable
- Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial RednessCompletedNCT01529996Not applicable
- A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With RosaceaCompletedNCT01513863Phase 1
- A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155)CompletedNCT01451619Phase 1
- Safety, Tolerability and Efficacy of BFH772 in Rosacea PatientsCompletedNCT01449591Phase 2
- Rifaximin Treatment of Papulopustular RosaceaWithdrawnNCT01359228Phase 2
- Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular RosaceaCompletedNCT01257919Phase 1
- Dose Response Study of Patients With Erythematous RosaceaCompletedNCT01186068Phase 2
- Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea PatientsTerminatedNCT01134991Phase 2
- Study of 0444 Gel in the Treatment of Inflammatory Lesions of RosaceaCompletedNCT01016782Phase 3
- The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of PhotodamageCompletedNCT00991198Phase 2
- Combination Therapy for the Treatment of RosaceaCompletedNCT00945373Phase 1
- Isotretinoin in Papular-Pustular RosaceaCompletedNCT00882531Phase 3
- Potential Research Study Participant RegistryCompletedNCT00710489
- Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal NeovasculizationCompletedNCT00681603Not applicable
- An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%CompletedNCT00668655
- A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With RosaceaCompletedNCT00667173Phase 2
- A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of RosaceaCompletedNCT00621218Phase 2
- Safety and Efficacy Study to Compare Two Rosacea Treatment RegimensCompletedNCT00495313Phase 4
- Laser-Mediated Photodynamic Therapy of Acne Vulgaris and RosaceaCompletedNCT00483145Not applicable
- Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single ApplicationCompletedNCT00436527Phase 4
- A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once DailyCompletedNCT00417937Phase 4
- Efficacy of Topical Cyclosporin for Ocular RosaceaCompletedNCT00348335Phase 4
- Topical Agent for Treatment of Red SkinCompletedNCT00279890Phase 1
- A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.CompletedNCT00249782Phase 2
- A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of RosaceaCompletedNCT00126399Phase 3
- Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne RosaceaCompletedNCT00041977Phase 3